HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY RESULTS IN A DECREASE IN CD8(-CELL ACTIVATION AND PREFERENTIAL RECONSTITUTION OF THE PERIPHERAL CD4(+)T-CELL POPULATION WITH MEMORY RATHER THAN NAIVE CELLS() T)
Tg. Evans et al., HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY RESULTS IN A DECREASE IN CD8(-CELL ACTIVATION AND PREFERENTIAL RECONSTITUTION OF THE PERIPHERAL CD4(+)T-CELL POPULATION WITH MEMORY RATHER THAN NAIVE CELLS() T), Antiviral research, 39(3), 1998, pp. 163-173
Objective: Highly active antiretroviral therapy (HAART) can produce ma
rked increases in peripheral blood CD4(+) T cells and decreases in HIV
plasma RNA copy numbers. However, it is not clear whether these absol
ute changes will be accompanied by a recovery in the known naive CD4() T cell depletion or a decrease in the marked CD8(+) T cell activatio
n. Design: Twenty-nine patients were enrolled in studies of either nuc
leoside therapy alone or nucleoside therapy combined with a protease i
nhibitor (zidovudine + lamivudine + indinavir). One hundred and ninety
-one examinations were carried out at three baseline time points and d
uring 40 weeks of follow-up to evaluate the effect of HAART on CD4(+)
memory/naive phenotype and CD8(+) T cell activation. Methods: CD4(+) a
nd CD8(+) T cell number, CD62L/CD45RA expression on CD4(+) T cells and
CD38 expression on CD8(+) T cells were measured by three-color flow c
ytometry. Results: Most protease inhibitor treated patients had a sign
ificant rise in CD4(+) numbers. The marked rise in the CD4(+) T cells
seen in individuals in this study was not accompanied over a 40-week p
eriod by a change ill the abnormally low CD4(+) naive compartment, and
thus was almost completely of memory phenotype. The CD38 expression o
n CD8(+) cells fell during treatment, and decreased to a greater degre
e than the comparable rise in CD4(+) T cell counts. This decrease cont
inued in many patients after the CD4(+) T cell rise or viral load decl
ine had plateaued. Conclusion: HAART results in changes in activation
to a greater extent than absolute changes in CD4(+) T cell numbers, bu
t is not accompanied by an increase in naive CD4(+) T cells. Measureme
nts of CD4(+) T cell numbers alone may not allow appropriate interpret
ation of immune activation or immune competence in patients receiving
those drugs. (C) 1998 Elsevier Science B.V. All rights reserved.